M. Markowitz

Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.

M. Bock, R. Freidinger, R. Chang, 2004, European journal of pharmacology.

Discovery of a potent, non-peptide bradykinin B1 receptor antagonist.

M. Bock, R. M. Dipardo, R. Freidinger, 2003, Journal of the American Chemical Society.

μ-Bis(cyanotrihydroborato)-tetrakis(triphenylphosphine) dicopper(I). A new, selective, pH dependent reducing agent

R. O. Hutchins, M. Markowitz, 1980 .

Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1.

M. Bock, R. Freidinger, R. Chang, 2005, Biochemical and biophysical research communications.

Tetraalkylammonium trihydridocyanoborates. Versatile, selective reagents for reductive aminations in nonpolar media

R. O. Hutchins, M. Markowitz, 1981 .

Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes.

M. Bock, R. Freidinger, R. Chang, 2007, Bioorganic & medicinal chemistry letters.

Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies.

M. Bock, R. Freidinger, R. Chang, 2004, Bioorganic & Medicinal Chemistry Letters.

Generation and Characterization of a Human Bradykinin Receptor B1 Transgenic Rat as a Pharmacodynamic Model

M. Bock, R. M. Dipardo, R. Chang, 2004, Journal of Pharmacology and Experimental Therapeutics.